Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,790 | -10,814 | -29,352 | -30,197 | -15,379 |
| Depreciation Amortization | 276 | 140 | 593 | 448 | 302 |
| Accounts receivable | 13,322 | 12,846 | -12,389 | 996 | 306 |
| Accounts payable and accrued liabilities | -6,808 | -8,072 | 923 | -493 | 1,141 |
| Other Working Capital | 8,100 | 5,746 | -13,041 | 1,948 | 2,062 |
| Other Operating Activity | -3,841 | -3,302 | 13,442 | 123 | -3,537 |
| Operating Cash Flow | $-10,741 | $-3,456 | $-39,824 | $-27,175 | $-15,105 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,390 | 9,000 | -30,457 | -27,912 | -27,443 |
| PPE Investments | N/A | N/A | -33 | -33 | -33 |
| Investing Cash Flow | $12,390 | $9,000 | $-30,490 | $-27,945 | $-27,476 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,667 | -1,333 | -444 | N/A | N/A |
| Common Stock Issued | 1 | N/A | 64,170 | 64,223 | 64,176 |
| Common Stock Repurchased | N/A | N/A | 54 | N/A | 32 |
| Other Financing Activity | -45 | -45 | -289 | -120 | -114 |
| Financing Cash Flow | $-2,711 | $-1,378 | $63,491 | $64,103 | $64,094 |
| Exchange Rate Effect | -13 | -12 | 44 | 710 | 643 |
| Beginning Cash Position | 36,439 | 36,439 | 43,218 | 43,218 | 43,218 |
| End Cash Position | 35,364 | 40,593 | 36,439 | 52,911 | 65,374 |
| Net Cash Flow | $-1,075 | $4,154 | $-6,779 | $9,693 | $22,156 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,741 | -3,456 | -39,824 | -27,175 | -15,105 |
| Capital Expenditure | N/A | N/A | -33 | -33 | -33 |
| Free Cash Flow | -10,741 | -3,456 | -39,857 | -27,208 | -15,138 |